The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 480.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.167%)
Open: 490.00
High: 490.00
Low: 490.00
Prev. Close: 490.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Apr 2023 07:00

RNS Number : 8896V
System1 Group PLC
12 April 2023
 

 

 

12 April 2023

 

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

Final Quarter Trading Update

 

 

System1 today issues an update on trading for the quarter ended 31 March 2023 (Q4).

 

 

FY23

Revenue £ million - unaudited *

Q1

Q2

H1

Q3

Q4

H2

FY

Jun-22

Sep-22

Dec-22

Mar-23

Mar-23

Predict Your (data)

2,964

3,189

6,153

3,400

4,107

7,507

13,660

Improve Your (data-led consultancy)

752

694

1,446

862

1,163

2,025

3,471

Standard (platform revenue)

3,716

3,883

7,599

4,262

5,270

9,532

17,131

Other consultancy (non-platform)

1,529

1,368

2,897

1,964

1,354

3,318

6,215

Total Revenue

5,245

5,251

10,496

6,226

6,624

12,850

23,346

 

 * The Company has disclosed additional information in relation to the breakdown of revenues, which it intends to provide going forward. All numbers in this announcement are unaudited and therefore may be subject to change.

 

During Q4, the Company made substantial and measurable progress towards the strategic objectives that the board set out following the strategic review, specifically growing our standard Predict Your and Improve Your products (platform-based data and consultancy) to a point where they represented 80% of revenue in Q4.

Predict Your (data) revenue grew by 67% on the comparable prior-year quarter to £4.1m, a quarterly record, and by 40% for the financial year to £13.7m. Improve Your (data-led consultancy) revenue increased by 95% over the comparable prior-year quarter and by 29% for the financial year overall. Standard product revenues therefore grew by 73% on Q4 FY22 and by 38% for the financial year and represented 80% of revenues in Q4 and 73% for the financial year.

For the year as a whole, Other Consultancy (non-platform) revenue was £5.5m lower at £6.2m. In H2 Other Consultancy revenue grew on H1, following three successive periods of half-on-half reduction, reinforcing the Board's belief that the decline in non-strategic revenue is substantially behind us.

Total Group revenue rose by 26% in Q4 and 9% in H2 ending the year at £23.3m, 3% lower than FY22 (standard platform revenue +38%, Other non-platform consultancy -47%).

Excellent progress was made in the US in Q4 where we won new mandates from 3 of the country's 25 biggest advertising spenders, including the largest. The US delivered its highest half year of revenue since FY21, and standard product revenue increased by 23% for the year as a whole.

 

Following the launch of Test Your Idea, Innovation product revenue increased by 28% in H2 versus H1. Communications products, primarily Test Your Ad, continued to grow by over 20% H2 on H1. Brand grew by 12% year on year, helped by the first full year of Test Your Brand.

 

The improved revenue performance in H2 is expected to bring a return to profitability at adjusted and statutory levels for H2 and also for the year as a whole, based on the unaudited management accounts, and the Board now anticipates that profit for the year ended 31 March 2023 will slightly exceed its previous expectations. As indicated in the 23 February 2023 trading update, there was a cash inflow during Q4, resulting in year-end net cash of £5.7m.

 

Commenting on the results, CEO James Gregory said: "I am delighted with the upturn in performance in the second half-year. The profitable growth in our standard, platform-based products in the US and elsewhere demonstrates that we have the right strategy, business model and management team."

 

General Meeting 21 April

The company has called a general meeting for 21 April 2023 to consider four resolutions proposed by shareholders Stefan Barden and James Geddes ("Requisitioning Shareholders"). The Board believes that the latest quarter's trading performance demonstrates that the company's product and go-to-market strategy is correct, and that management is executing the plan effectively. We repeat our recommendation in the Circular dated 24 March 2023 that the Board considers that all the resolutions proposed by the Requisitioning Shareholders are not in the best interest of the Company and the shareholders as a whole, and that the Board will be voting against all of them and unanimously recommends that shareholders do the same.

 

Further information on the Company can be found at www.system1group.com.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited (Nominated Adviser & Broker)

Tel: +44 (0)20 7523 8000

 

Simon Bridges / Andrew Potts

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBQCBKDKQD
Date   Source Headline
11th Sep 20139:51 amRNSHolding(s) in Company
7th Aug 20133:30 pmRNSHolding(s) in Company
12th Jul 201311:23 amRNSTransaction in Own Shares
11th Jul 20137:00 amRNSTrading Update
22nd May 201311:05 amRNSResult of AGM
3rd May 20132:52 pmRNSTransaction in Own Shares
16th Apr 20131:53 pmRNSNotice of AGM
15th Apr 20133:58 pmRNSAnnual Financial Report
21st Mar 20137:01 amRNSDividend Declaration
21st Mar 20137:00 amRNSResults for the 12 Months ended 31 Dec 2012
18th Jan 20133:59 pmRNSTransaction in Own Shares
17th Jan 201310:43 amRNSTrading Update
24th Dec 201211:52 amRNSTransaction in Own Shares
20th Nov 20127:00 amRNSTrading Update
26th Oct 201211:15 amRNSTransaction in Own Shares
18th Oct 20125:39 pmRNSHolding(s) in Company
15th Oct 20125:40 pmRNSTransaction in Own Shares
2nd Oct 20127:00 amRNSDirectorate Change
27th Sep 20128:02 amRNSDirector Dealing
25th Sep 20127:00 amRNSTransaction in Own Shares
20th Sep 20127:00 amRNSHalf Yearly Report
27th Jul 20128:58 amRNSUpdate of adviser details
19th Jul 20121:05 pmRNSTransaction in Own Shares
19th Jul 20127:00 amRNSTrading Statement
13th Jul 20127:00 amRNSAwards under Value Creation Plan
12th Jul 20127:38 amRNSDirector/PDMR Shareholding
6th Jul 20125:49 pmRNSTransaction in Own Shares
27th Jun 20126:06 pmRNSTransaction in Own Shares
29th May 20126:15 pmRNSTransaction in Own Shares
29th May 20124:54 pmRNSDirector dealing & appointment
23rd May 20124:23 pmRNSResult of AGM
23rd Apr 20127:00 amRNSDirector Dealing
17th Apr 20126:32 pmRNSTransaction in Own Shares
12th Apr 20125:04 pmRNSTransaction in own Shares
11th Apr 20121:46 pmRNSAnnual Report and Accounts
22nd Mar 20127:00 amRNSResults for 12 Months ended 31 Dec 2011
20th Jan 20125:39 pmRNSTransaction in Own Shares
19th Jan 20127:00 amRNSTrading Update
16th Jan 20127:47 amRNSTransaction in Own Shares
10th Jan 20122:31 pmRNSTransaction in Own Shares
5th Jan 20121:24 pmRNSDirectorate Change
2nd Dec 20117:00 amRNSTransaction in Own Shares
22nd Nov 20119:35 amRNSTransaction in Own Shares
3rd Nov 20113:23 pmRNSTransaction in Own Shares
2nd Nov 20115:39 pmRNSTransaction in Own Shares
1st Nov 20115:47 pmRNSTransaction in Own Shares
31st Oct 20114:14 pmRNSTransaction in Own Shares
29th Sep 20115:09 pmRNSDirector/PDMR Shareholding
12th Sep 20118:29 amRNSBlocklisting Interim Review
30th Aug 20119:52 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.